David C. Metz

11.1k total citations · 3 hit papers
188 papers, 6.2k citations indexed

About

David C. Metz is a scholar working on Surgery, Epidemiology and Gastroenterology. According to data from OpenAlex, David C. Metz has authored 188 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Surgery, 69 papers in Epidemiology and 66 papers in Gastroenterology. Recurrent topics in David C. Metz's work include Helicobacter pylori-related gastroenterology studies (68 papers), Neuroendocrine Tumor Research Advances (61 papers) and Gastroesophageal reflux and treatments (57 papers). David C. Metz is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (68 papers), Neuroendocrine Tumor Research Advances (61 papers) and Gastroesophageal reflux and treatments (57 papers). David C. Metz collaborates with scholars based in United States, France and Canada. David C. Metz's co-authors include Robert T. Jensen, Yu‐Xiao Yang, Colin W. Howden, Doris B. Strader, Joseph J.�Y. Sung, Murray Orbuch, James Y. Lau, Catherine Hill, Shria Kumar and David S. Goldberg and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David C. Metz

178 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors

2008 538 citations David C. Metz, Robert T. Jensen Gastroenterology profile →
Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production

2014 381 citations Lisa Nessel, David C. Metz et al. profile →
Systematic Review of the Epidemiology of Complicated Peptic Ulcer Disease: Incidence, Recurrence, Risk Factors and Mortality

2011 371 citations Colin W. Howden, David C. Metz et al. profile →

Peers

Countries citing papers authored by David C. Metz

Since Specialization

Citations

This map shows the geographic impact of David C. Metz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Metz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Metz more than expected).

Fields of papers citing papers by David C. Metz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Metz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Metz. The network helps show where David C. Metz may publish in the future.

Co-authorship network of co-authors of David C. Metz

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Metz. A scholar is included among the top collaborators of David C. Metz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Metz. David C. Metz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms 2025 ·Cancer ·David Su, Leanne Brown, (unknown), (unknown), Seth J. Concors, Kiran K. Turaga, Craig G. Gunderson, Emily K. Bergsland, Jonathan Strosberg, Þorvarður R. Hálfdánarson, David C. Metz, John W. Kunstman, Pamela L. Kunz, Alexandra Gangi	0
2	Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms 2025 ·Annals of Surgical Oncology ·David Su, Leanne Brown, (unknown), (unknown), Seth J. Concors, Kiran K. Turaga, Craig G. Gunderson, Emily K. Bergsland, Jonathan Strosberg, Þorvarður R. Hálfdánarson, David C. Metz, John W. Kunstman, Pamela L. Kunz, Alexandra Gangi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
3	Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues 2022 ·Nature Cancer ·Zijie Feng, Xin He, Xuyao Zhang, Yuan Wu, Bowen Xing, (unknown), Qiaonan Shan, Samuel I. Miller, (unknown), Jian Ma, Bryson W. Katona, T. Gade, Don L. Siegel, Jörg Schrader, David C. Metz, Carl H. June, Xianxin Hua	69
4	Presacral neuroendocrine tumors associated with the Currarino syndrome 2021 ·American Journal of Medical Genetics Part A ·Aaron T. Scott, (unknown), Terry A. Braun, Bartley Brown, Patrick Breheny, Benjamin W. Darbro, Andrew M. Bellizzi, Joseph S. Dillon, Thomas M. O’Dorisio, (unknown), (unknown), John Bernat, David C. Metz, James R. Howe	3
5	Low Rates of Retesting for Eradication of Helicobacter pylori Infection After Treatment in the Veterans Health Administration 2020 ·Clinical Gastroenterology and Hepatology ·Shria Kumar, David C. Metz, David E. Kaplan, David S. Goldberg	22
6	Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study 2019 ·Gastroenterology ·Shria Kumar, David C. Metz, Susan S. Ellenberg, David E. Kaplan, David S. Goldberg	188
7	The impact of surgery for metastatic pancreatic neuroendocrine tumor: a contemporary evaluation matching for chromogranin a level 2019 ·HPB ·Seth J. Concors, Andrew J. Sinnamon, Brett L. Ecker, David C. Metz, Charles M. Vollmer, Douglas L. Fraker, Robert E. Roses	11
8	Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome : Patient Exit Interviews 2016 ·Pancreas ·Lowell Anthony, Dieter Hoersch, (unknown), Matthew H. Kulke, Marianne Pavel, Emily K. Bergsland, Martyn Caplin, Kjell Öberg, Richard R.P. Warner, Pamela L. Kunz, David C. Metz, Janice L. Pasieka, Nick Pavlakis, Dana DiBenedetti, (unknown), Qi Yang, Shanna Jackson, (unknown), Linda Law, Pablo Lapuerta	1
9	Consensus on biomarkers for neuroendocrine tumour disease 2015 ·The Lancet Oncology ·Kjell Öberg, Irvin M. Modlin, Wouter W. de Herder, Marianne Pavel, David S. Klimstra, Andrea Frilling, David C. Metz, Anthony P. Heaney, Dik J. Kwekkeboom, Jonathan Strosberg, T Meyer, Steven F. Moss, Kay Washington, Edward M. Wolin, Eric Liu, James R. Goldenring	206
10	Weight Gain in Zollinger-Ellison Syndrome After Acid Suppression 2015 ·Pancreas ·Brian P. Riff, David A. Leiman, (unknown), Douglas L. Fraker, David C. Metz	4
11	A prospective, randomized, comparative trial evaluating respiratory depression during patient-controlled versus anesthesiologist-administered propofol-remifentanil sedation for elective colonoscopy 2010 ·Gastrointestinal Endoscopy ·Jeff E. Mandel, Gary R. Lichtenstein, David C. Metz, Gregory G. Ginsberg, Michael L. Kochman	20
12	Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity 2008 ·Pharmacoepidemiology and Drug Safety ·James D. Lewis, Brian L. Strom, A. Russell Localio, David C. Metz, John T. Farrar, Robert M. Weinrieb, Lisa Nessel, Colleen Brensinger, Stephen E. Kimmel	50
13	Idiopathic gastric acid hypersecretion presenting as a diarrheal disorder and mimicking both Zollinger???Ellison syndrome and Crohn??s disease 2005 ·European Journal of Gastroenterology & Hepatology ·Wojciech Błoński, David A. Katzka, Gary R. Lichtenstein, David C. Metz	6
14	Hepatitis C Knowledge among Primary Care Residents: Is Our Teaching Adequate for the Times? 2004 ·The American Journal of Gastroenterology ·Angelo Coppola, (unknown), David C. Metz, Mae F. Go, (unknown), Colin W. Howden, Jean-Pierre Raufman, Virender K. Sharma	34
15	Intravenous and oral lansoprazole are equivalent in suppressing stimulated acid output in patient volunteers with erosive oesophagitis 2004 ·Alimentary Pharmacology & Therapeutics ·T. O. G. Kovacs, (unknown), Yen‐Ling Chiu, Betsy Pilmer, David C. Metz	15
16	Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials 2004 ·The American Journal of Medicine ·David A. Peura, Thomas O. Kovacs, David C. Metz, Nancy Siepman, Betsy Pilmer, Nicholas J. Talley	80
17	Esophageal dilation is safe despite increasing complexity of strictures 2001 ·Gastrointestinal Endoscopy ·Ronald J. Lew, Gregory G. Ginsberg, William B. Long, David C. Metz, David A. Katzka, Michael L. Kochman	1
18	Comparison of Rapid Office-Based Serology with Formal Laboratory-Based ELISA Testing for Diagnosis of Helicobacter pylori Gastritis 1998 ·Digestive Diseases and Sciences ·(unknown), Douglas O. Faigel, Emma E. Furth, David C. Metz	15
19	Use of omeprazole in Zollinger‐Ellison syndrome: a prospective nine‐year study of efficacy and safety 1993 ·Alimentary Pharmacology & Therapeutics ·David C. Metz, Doris B. Strader, Murray Orbuch, (unknown), Kathryn Feigenbaum, Robert T. Jensen	71
20	Flow cytometry and Zollinger-Ellison syndrome: Relationship to clinical course 1993 ·Gastroenterology ·David C. Metz, (unknown), (unknown), David Venzon, Gitie Jaffe, Robert T. Jensen, M Stetler-Stevenson	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact